Opportunities and challenges of developing thermostable vaccines. - Wikidata - awgldk - TriplyDB

Opportunities and challenges of developing thermostable vaccines.

Opportunities and challenges of developing thermostable vaccines.

http://www.wikidata.org/entity/Q37461354

about

Entirely Carbohydrate-Based Vaccines: An Emerging Field for Specific and Selective Immune Responses Development of a Freeze-Dried, Heat-Stable Influenza Subunit Vaccine Formulation Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013 Experimental vaccines against potentially pandemic and highly pathogenic avian influenza viruses An evaluation of respiratory administration of measles vaccine for prevention of acute lower respiratory infections in children.Towards preserving the immunogenicity of protein antigens carried by nanoparticles while avoiding the cold chain.Micro-fractional epidermal powder delivery for improved skin vaccination Frequent exposure to suboptimal temperatures in vaccine cold-chain system in India: results of temperature monitoring in 10 states.Vibrio cholerae: lessons for mucosal vaccine design.Thermostable cross-protective subunit vaccine against Brucella species Program on immunization and cold chain monitoring: the status in eight health districts in Cameroon.A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution.Needle-Free Dermal Delivery of a Diphtheria Toxin CRM197 Mutant on Potassium-Doped Hydroxyapatite Microparticles.Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2 A thermostable, chromatographically purified Ebola nano-VLP vaccine.RETRACTED: Stabilization of vaccines and antibiotics in silk and eliminating the cold chain.A long-lasting, single-dose nasal vaccine for Ebola: a practical armament for an outbreak with significant global impact Tools and approaches to ensure quality of vaccines throughout the cold chain Can thermostable vaccines help address cold-chain challenges? Results from stakeholder interviews in six low- and middle-income countries.Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches.The impact of making vaccines thermostable in Niger's vaccine supply chain Thermal stability of self-assembled peptide vaccine materials.Optimized Formulation of a Thermostable Spray-Dried Virus-Like Particle Vaccine against Human Papillomavirus Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice Thermostabilization of inactivated polio vaccine in PLGA-based microspheres for pulsatile release.Stabilization of a recombinant ricin toxin A subunit vaccine through lyophilization.A high-performance thioredoxin-based scaffold for peptide immunogen construction: proof-of-concept testing with a human papillomavirus epitope.Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses.Intradermal powder immunization with protein-containing vaccines.Development of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvant.Immunological evaluation of the entirely carbohydrate-based Thomsen-Friedenreich - PS B conjugate.[Impact of Controlled Temperature Chain (CTC) approach on immunization coverage achieved during the preventive vaccination campaign against meningitis A using MenAfriVac in Togo in 2014].Polyelectrolyte-Enrobed Cancer Cells in View of Personalized Immune-Therapy Stabilization of HAC1 influenza vaccine by spray drying: formulation development and process scale-up.Development of thermostable lyophilized inactivated polio vaccine.An economic evaluation of the controlled temperature chain approach for vaccine logistics: evidence from a study conducted during a meningitis A vaccine campaign in Togo.Developments in the formulation and delivery of spray dried vaccines.A thermostable messenger RNA based vaccine against rabies.Brazilian meningococcal C conjugate vaccine: physicochemical, immunological, and thermal stability characteristics.Fabrication of fillable microparticles and other complex 3D microstructures.

P2860

Q26746887-2798B765-6BE1-4297-B5FF-DDB1532C1DF2 Q28553530-A58F27E5-0CA7-4F9F-BC67-B8DC1B847415 Q28654939-95AAD9F4-BE42-4D68-95E9-E5A568F1A310 Q30427591-DF0BB8A8-B764-4373-9798-9842E218AD50 Q33875725-9106C7CC-1C0A-4B62-8C28-EDD569CF297A Q33946847-3F6BF18D-04DE-4B23-8B7F-060E7BFC1CF0 Q34229340-0323074E-B011-4DC4-939B-4AD66F23E251 Q34392576-F7D8595A-E4B8-4285-923A-3B1FF6F2A10C Q34562952-2E258C06-763C-49EF-9F36-08184CCD9BCA Q34593053-FF567911-56FE-4845-A79C-3E53D6F29B52 Q34623777-9065B1C1-0085-4783-A31D-3F34D5EC3E8B Q35268788-825264E7-EC56-41E1-BC53-8BF5B403A437 Q35548057-3CEBA0B2-D8F1-4EC1-B7BD-558586FC9E25 Q35744303-1014E31C-A086-4529-BDFA-F99456B1A088 Q35853669-4282E7DB-DC67-4918-B891-CE2EF1EEF5AF Q36132649-FAD49C1B-7180-4897-9601-1662045821D7 Q36474341-DB2EB111-41E1-4D7D-970F-9F38BC472496 Q36550989-4C75998A-7252-4A78-AA49-7725C8C620ED Q36552323-90518AD4-72A2-4BA2-9CE2-6A7C4ECA6C12 Q36649709-8245285F-E3B3-4E9E-9F63-C5087930A02A Q36670247-F956B99D-F23A-4B3E-B328-30B3C47CF2AB Q36766037-444E7FFE-B92D-4E7E-B183-ADB314E3150C Q36858686-2C66DFBC-D59C-4927-AB43-7024631EC5CD Q36996938-A03855A6-E885-47AD-A768-58EA6EF92654 Q37048185-845BCEE6-2A44-4732-AE02-B46E868B98B7 Q37231025-512BAE22-41A1-4F01-A3DA-360F4C13D3FC Q37714750-750AE75E-C697-4F69-B508-77A7711DEC74 Q37785952-2AFD3892-20B0-4299-8E79-D03B34F50236 Q38113271-E989668C-9E97-4CA6-BFC3-BE8A004DCF16 Q38678186-10C4DC57-8E1B-43F0-A22B-E5C1C8B24216 Q39935587-ADF048C6-ABBB-469B-98BE-E31C48F30EC7 Q40045360-B5C2124A-7CA5-4EC1-9598-EA42FDD77CD1 Q42199258-64443187-783A-4AC9-B4A4-C189C77BA6F3 Q42213924-9B51AC1E-EEE9-4DE7-8FE4-5C4A0A887313 Q42222649-E0329658-D6C0-4813-A151-F95FFB8BA20B Q47104963-F28D7709-9EDB-41B6-8B13-E50A80A09DC8 Q47106090-6EFEB15F-DA5D-48B4-9393-C08C96D8C8D2 Q47150463-B3E9C0FB-0F84-4FD2-9D0F-DA67D0741C6F Q47774166-A4BA89C1-F077-42BC-A16F-02424CBA7CC5 Q48344306-1F128FFD-4BF5-43A1-9839-2D36A5C95BD3

P2860

Opportunities and challenges of developing thermostable vaccines.

http://www.wikidata.org/entity/Q37461354

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Opportunities and challenges of developing thermostable vaccines.

@en

Opportunities and challenges of developing thermostable vaccines.

@nl

type

label

Opportunities and challenges of developing thermostable vaccines.

@en

Opportunities and challenges of developing thermostable vaccines.

@nl

prefLabel

Opportunities and challenges of developing thermostable vaccines.

@en

Opportunities and challenges of developing thermostable vaccines.

@nl

P1433

Q37461354-197F5DFB-801D-4D9A-9465-E26C890B54AA

P1476

Q37461354-D19A00DD-F110-45FF-AB94-A32457F60BF5

P2093

Q37461354-0CDFEE45-5BC4-4D5E-A6B1-B186545DF4FB

Q37461354-E4DD0211-58B3-4872-A50D-1B082E956534

P2860

Q37461354-03076B62-686C-45BC-916F-9E9F73957D81

Q37461354-0C046DD5-A91B-4FE0-B73D-BEFB0F8CC76A

Q37461354-15AAC2F8-1D95-4CB4-BF4B-8F412D15D0A0

Q37461354-36398C01-0293-49C8-99C1-07F64D0DA23C

Q37461354-42A9FE57-C902-40E2-8362-F74C931B8C0E

Q37461354-47C78BF6-9392-45A4-A320-DB29757AF6F8

Q37461354-505AC856-FF27-4D7E-8181-72BA3460C6B3

Q37461354-51966B46-3C9A-4091-9F32-A8150CF3A2E9

Q37461354-5BCF886E-3EC0-4071-82BD-7290ED6F3412

Q37461354-639F704D-2921-4946-84FD-1D729849D462

P304

Q37461354-ACDB0A3B-5145-45F5-9B80-2B8C372E0508

P31

Q37461354-EAD3378E-9474-4706-8135-A4DF0B5358D3

P356

Q37461354-19CFF17A-4183-4559-B896-86725A343084

P433

Q37461354-341AE732-BC6C-46B1-B0DA-D7863404D8DB

P478

Q37461354-764685BE-1AFF-4372-BD89-199CE895799F

P577

Q37461354-436A24CA-0B57-45C7-A388-2066772706E1

P5875

Q37461354-81E36B68-03E2-45BC-BCE1-6C461FAC364D

P698

Q37461354-A7DAB555-8CDA-4EED-AD14-AF26BD0661D8

P356

P1433

Expert Review of Vaccines

P1476

Opportunities and challenges of developing thermostable vaccines.

@en

P2093

Debra Kristensen

http://www.w3.org/2001/XMLSchema#string

Dexiang Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Generalized cost-effectiveness analysis for national-level priority-setting in the health sector

Fast dynamics and stabilization of proteins: binary glasses of trehalose and glycerol.

At-birth immunisation against hepatitis B using a novel pre-filled immunisation device stored outside the cold chain.

Improving birth dose coverage of hepatitis B vaccine.

High-throughput screening of stabilizers for respiratory syncytial virus: identification of stabilizers and their effects on the conformational thermostability of viral particles.

Instability, stabilization, and formulation of liquid protein pharmaceuticals.

The role of vitrification in anhydrobiosis.

Drying a tuberculosis vaccine without freezing

Freezing temperatures in the vaccine cold chain: a systematic literature review.

Hepatitis B vaccination of newborn infants in rural China: evaluation of a village-based, out-of-cold-chain delivery strategy.

P304

547-557

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERV.09.20

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24364538

http://www.w3.org/2001/XMLSchema#string

P698

19397412

http://www.w3.org/2001/XMLSchema#string